AN1 0.00% 0.7¢ anagenics limited

Ann: Cellmid to Commence Selling of Evolis into Chinese Market, page-5

  1. 356 Posts.
    lightbulb Created with Sketch. 56
    Technical commissioning service
    Technology commissioned R&D services can be provided to complete the entire process of R&D, R&D, pilot, and large-scale production.

    Registration consulting
    Provide domestic and foreign companies with registration and market access services for pharmaceuticals, health products and medical devices in mainland China.

    Production and processing
    The company has a pharmaceutical factory and a raw material pharmaceutical factory in Foshan and Liaoyuan. It can provide solid preparations, tablet raw materials and intermediates,
    etc.

    GMP plant construction
    Including assisting in the construction of GMP plant, training of GMP standard personnel.

    Clinical research
    He has rich clinical research experience in China, including 1-4 clinical studies.

    commercialize
    Has a strong sales team in the country.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $350 50K

Buyers (Bids)

No. Vol. Price($)
4 775527 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 5022 1
View Market Depth
Last trade - 11.14am 09/08/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.